Table 3 Predictive KHORANA model for chemotherapy-associated VTE in ambulatory cancer patients [38]
From: Venous thromboembolism in cancer patients: an underestimated major health problem
Risk factors | Number |
|---|---|
Cancer-related risk factors | Â |
 Site of cancer and tumor histotype | 2 |
 Very high risk (stomach adenocarcinoma, pancreas | 1 |
adenocarcinoma) | Â |
 High risk (lung, lymphoma, gynecological, bladder, |  |
testicular) | 1 |
Hematological risk factors | 1 |
 Prechemotherapy platelet count ±350,000/l | 1 |
 Hemoglobin <10 g/dl or use of ESA growth factors |  |
 Prechemotherapy leukocyte count >11 000/l | 1 |
Patient-related risk factor | Â |
 Body mass index ±35 kg/m2 |  |